Somnigroup International Inc. Q2 FY26 Earnings Analysis

- Full-year 2026 sales midpoint guidance is approximately $7.8 billion, slightly down from prior $7.9 billion due to lower industry outlook but offset by price increases and share gains. - Global bedding industry expected to be flat to slightly down year-over-year. - Like-for-like sales growth anticipated: Tempur Sealy North America mid-single digits, International mid-single digits, Mattress Firm low single digits. - Pricing actions predicted to add ~$50 million in sales lift in back half of 2026 and ~$100 million annualized. - Stearns & Foster new product lineup launching in 2H 2026 expected to support higher ASP and addressable market expansion. - International business continues double-digit (reported) and mid-single-digit (constant currency) growth, outperforming broader market. - Mattress Firm expected to contribute an incremental $40 million EBITDA benefit in 2026 compared to 2025 with ongoing store refresh and product assortment enhancements. - Overall, growth is supported by share gains, pricing architecture optimization, and geographic expansion.

- Full-year 2026 adjusted EPS guidance is between $3.00 and $3.40 per share. - Expected EPS growth in 2Q 2026 is between 5% and 10% despite a challenging market. - Commodity inflation expected to be neutral to full-year 2026 earnings due to pricing actions. - Expected adjusted EBITDA for 2026 is approximately $1.45 billion at the midpoint. - Sales synergies and cost synergies have provided $50 million each in adjusted EBITDA in Q1 2026. - The combination with Leggett & Platt is expected to be accretive to adjusted EPS within the first year post-closing. - Operational efficiencies and synergies expected to deliver nearly 100 basis points of net margin expansion in 2026. - Focus on continued growth in North America and international markets with mid-single-digit sales growth targets.

- 2026 Capital Expenditures (CapEx) expected to be approximately $225 million. - Includes $75 million specifically for Mattress Firm store refreshes and brand wall installation. - CapEx expected to normalize to $200 million in future years. - Ongoing $150 million Mattress Firm store refresh program targeting completion in 2027 (approximately $40 million spent to date). - Strategic combination agreement with Leggett & Platt expected to close by year-end 2026. - Leggett & Platt will operate as a separate business unit, supporting expanded market opportunities and vertical integration. - Combination expected to realize at least $50 million in EBITDA synergies.

- No explicit mention of current or future new fundraising through debt or equity in the provided transcript. - The company highlights strong cash generation, disciplined capital allocation, and a target leverage ratio of 2 to 3x expected to be achieved in the coming months. - Capital expenditures for 2026 are expected at approximately $225 million, with normalization to $200 million in future years. - At least 50% of free cash flow in 2026 is planned to be returned to shareholders via dividends and share repurchases. - The announced combination with Leggett & Platt is an all-stock transaction valued at approximately $2.5 billion, including assumed debt, with no new fundraising from Somnigroup explicitly referenced. - The transaction is expected to be accretive to adjusted earnings per share within the first year before synergies.

The provided transcript does not specifically mention current or expected orderbook or pending orders. However, relevant insights related to demand and sales include: - Mattress Firm's same-store sales were flat in Q1 2026, with slight upswing in April. - Stearns & Foster launch planned for 2H 2026 to optimize price architecture and target higher price points. - International business delivered double-digit reported growth, mid-single-digit constant currency growth. - Other non-Mattress Firm North American retailers down 4% but slightly outperforming market. - Continued strength expected from advertising, product launches, and retailer support. - No explicit comment on orderbook or pending orders volume or backlog.